These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1489885)

  • 1. Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganese.
    Hagen PO; Davies MG; Schuman RW; Murray JJ
    J Vasc Res; 1992; 29(6):405-9. PubMed ID: 1489885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
    Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
    J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of perioperative storage solutions on long-term vein graft function and morphology.
    Davies MG; Hagen PO
    Ann Vasc Surg; 1994 Mar; 8(2):150-7. PubMed ID: 8198948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Trovato MJ; Barber L; Safi HJ; Hagen PO
    J Surg Res; 1999 Jun; 84(2):223-32. PubMed ID: 10357924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
    Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
    Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramipril and experimental vein graft intimal hyperplasia.
    Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
    Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of the regression of intimal hyperplasia in experimental vein grafts.
    Davies MG; Fulton GJ; Svendsen E; Hagen PO
    Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
    Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
    J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressors of oxygen metabolites fail to reduce vein graft intimal hyperplasia.
    Gates JD; Hirsch GM; Karnovsky MJ
    Arch Surg; 1995 Sep; 130(9):976-80. PubMed ID: 7661683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A free radical scavenger (Tempol) and its effect on intimal hyperplasia of vein grafts in rats.
    Türkmen A; Doğan M; Temel M
    Ulus Travma Acil Cerrahi Derg; 2018 Sep; 24(5):379-386. PubMed ID: 30394488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function.
    Klyachkin ML; Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):556-66. PubMed ID: 8078349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis.
    LaMuraglia GM; Klyachkin ML; Adili F; Abbott WM
    J Vasc Surg; 1995 Jun; 21(6):882-90; discussion 889-90. PubMed ID: 7776467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
    Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
    J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low molecular weight heparin on intimal hyperplasia in vein grafts.
    Wilson NV; Salisbury JR; Kakkar VV
    Eur J Vasc Surg; 1994 Jan; 8(1):60-4. PubMed ID: 8307218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radical attenuation prevents thrombosis and enables photochemical inhibition of vein graft intimal hyperplasia.
    Nigri GR; Kossodo S; Waterman P; Fungaloi P; LaMuraglia GM
    J Vasc Surg; 2004 Apr; 39(4):843-9. PubMed ID: 15071453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.